These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 25082520

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
    Romiti A, Cox MC, Sarcina I, Di Rocco R, D'Antonio C, Barucca V, Marchetti P.
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of metronomic chemotherapy in oncology: results from a national Italian survey.
    Collovà E, Sebastiani F, De Matteis E, Generali D, Aurilio G, Boccardo F, Crispino S, Cruciani G.
    Tumori; 2011 Jul; 97(4):454-8. PubMed ID: 21989433
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral vinorelbine in the treatment of non-small-cell lung cancer.
    Barletta G, Genova C, Rijavec E, Burrafato G, Biello F, Sini C, Dal Bello MG, Coco S, Truini A, Vanni I, Alama A, Beltramini S, Grassi MA, Boccardo F, Grossi F.
    Expert Opin Pharmacother; 2014 Aug; 15(11):1585-99. PubMed ID: 24972635
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer.
    Briasoulis E, Pappas P, Puozzo C, Tolis C, Fountzilas G, Dafni U, Marselos M, Pavlidis N.
    Clin Cancer Res; 2009 Oct 15; 15(20):6454-61. PubMed ID: 19808873
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preliminary evaluation of children treated with metronomic chemotherapy and valproic acid in a low-income country: Metro-Mali-02.
    Traore F, Togo B, Pasquier E, Dembélé A, André N.
    Indian J Cancer; 2013 Oct 15; 50(3):250-3. PubMed ID: 24061467
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment.
    Caffo O, Dipasquale M, Murgia V, Veccia A, Galligioni E.
    Expert Opin Drug Metab Toxicol; 2013 Aug 15; 9(8):1037-51. PubMed ID: 23705788
    [Abstract] [Full Text] [Related]

  • 19. Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer.
    Saloustros E, Kalbakis K, Vardakis N, Kalykaki A, Milaki G, Rovithi M, Agelaki S, Saridaki Z, Georgoulias V, Mavroudis D.
    J BUON; 2011 Aug 15; 16(2):215-8. PubMed ID: 21766488
    [Abstract] [Full Text] [Related]

  • 20. Vinorelbine (Navelbine) in non-small cell lung cancer: future directions.
    Crawford J.
    Semin Oncol; 1994 Oct 15; 21(5 Suppl 10):85-8. PubMed ID: 7526468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.